FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/07/071722 [Registered on: 31/07/2024] Trial Registered Prospectively
Last Modified On: 30/01/2026
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Process of Care Changes 
Study Design  Non-randomized, Multiple Arm Trial 
Public Title of Study   Development of a telestroke network to improve stroke care 
Scientific Title of Study   Development of a Telestroke Network to improve Stroke Care: A Quasi Experimental Study(TeStNet) 
Trial Acronym  TESTNET 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Biman Kanti Ray 
Designation  Professor 
Affiliation  BIN, IPGMER, Kolkata 
Address  Department of Neuromedicine, 2nd floor, Bangur Institute of neurosciences New Block, 52/1a, Sambhunath Pandit St, Gokhel Road, Bhowanipore

Kolkata
WEST BENGAL
700020
India 
Phone  9433185327  
Fax    
Email  bimankantiproject@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Biman Kanti Ray 
Designation  Professor 
Affiliation  BIN, IPGMER, Kolkata 
Address  Department of Neuromedicine, 2nd floor, Bangur Institute of Neurosciences New Block, 52/1a, Sambhunath Pandit St, Gokhel Road, Bhowanipore


WEST BENGAL
700020
India 
Phone  9433185327  
Fax    
Email  bimankantiproject@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Biman Kanti Ray 
Designation  Professor 
Affiliation  BIN, IPGMER, Kolkata 
Address  Department of Neuromedicine, 2nd floor, Bangur Institute of Neurosciences New Block, 52/1a, Sambhunath Pandit St, Gokhel Road, Bhowanipore


WEST BENGAL
700020
India 
Phone  9433185327  
Fax    
Email  bimankantiproject@gmail.com  
 
Source of Monetary or Material Support  
Institute of Postgraduate Medical Education and Research, Kolkata and ICMR, New Delhi 
 
Primary Sponsor  
Name  INDIAN COUNCIL OF MEDICAL RESEARCH 
Address  Ansari Nagar, New Delhi - 110029, India 
Type of Sponsor  Government funding agency 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 9  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Barun Das  Alipurduar District Hospital  Department of General Medicine, Hospital Rd, Ward no. 13, P.O. Alipurduar, PIN- 736121
Jalpaiguri
WEST BENGAL 
9831878735

drbarundas79@gmail.com 
Dr Amit Das  Basirhat Superspeciality Hospital  Department of General Medicine, Basirhat, PIN- 743412
North Twentyfour Parganas
WEST BENGAL 
9836372694

amit_das2904@rediffmail.com 
Dr Dipanjan Das  Bishnupur Superspeciality Hospital  Department of General Medicine, Ahalla Bai Road, Krishna Ganj, Bishnupur, PIN- 722122
Bankura
WEST BENGAL 
8902051838

dipanjan.das87@gmail.com 
Dr Sanat Kumar Jatua  Diamond Harbour Government Medical College and Hospital  Department of General Medicine, Haridanga, Newtown, Diamond Harbour, PIN- 743331
South Twentyfour Parganas
WEST BENGAL 
9830450225

drskjatua@gmail.com 
Dr Amitava Kundu  Islampur Superspeciality Hospital  Department of General Medicine, Sukanto Pally, PIN- 733202
Uttar Dinajpur
WEST BENGAL 
8250435706

dramtabhakundu@gmail.com 
Dr Sk Mohammad Yousuf  Jangipur Superspeciality Hospital  Department of General Medicine, RAGHUNATHGANJ, PIN- 742225
Murshidabad
WEST BENGAL 
9083557450

dr.skyousuf@gmail.com 
Dr Snehasis Das  Jhargram Government and Hospital  Department of General Medicine, Vidyasagar Pally, Jhargram, PIN- 721507
Medinipur
WEST BENGAL 
9433254978

snehasisds@gmail.com 
Dr Keshab Sinharay  Prafulla Chandra Sen Government Medical College and Hospital  Arambagh, PIN- 712601
Hugli
WEST BENGAL 
9433013147

keshabsinharay@gmail.com 
Dr Samir Kanta Datta  Suri Superspeciality Hospital  Departement of General Medicine, Suri Sadar Hospital Road, Sabuj Pally, Suri, PIN- 731101
Birbhum
WEST BENGAL 
9933713506

samirkantadatta@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
IPGME&R Research Oversite Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: I61||Nontraumatic intracerebral hemorrhage, (2) ICD-10 Condition: I63||Cerebral infarction,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Comprehensive Telestroke Model  Hospitals in group A will have telemedicine service in Hub-Spoke-Subspoke model and community awareness activities will be carried out in the district where these hospitals are situated. These hospitals will be connected to the sub centres and health & wellness centres of their district via telemedicine. Duration will be 1 year. 
Comparator Agent  Control  Hospitals in group C will have no telemedicine service and no community awareness activity. Duration will be 1 year. 
Comparator Agent  Conventional telestroke model  Hospitals in group B will have telemedicine service in Hub-and-spoke model. No community awareness activity will be conducted in the districts where these hospitals are situated. Duration will be 1 year. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  90.00 Year(s)
Gender  Both 
Details  • Aged 18 years & above.
• Resident of the study area.
 
 
ExclusionCriteria 
Details  1. Do not give consent for the study.
2. Resident of a district other than that of the study hospital.
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Proportion of stroke patients achieving MRS 0 to 2 at 90 days from onset of stroke.   90 days 
 
Secondary Outcome  
Outcome  TimePoints 
Proportion of stroke patient arriving within 4.5 hours  4.5 hours 
Onset-to-door time  7 days 
Onset-to-needle time in thrombolysed patients  4.5 hours 
Percentage of ischemic stroke patients thrombolysed  1 day 
MRS at discharge  7 days 
Treatment outcome  90 days 
 
Target Sample Size   Total Sample Size="1350"
Sample Size from India="1350" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   15/08/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Open to Recruitment 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details
Modification(s)  
• Ray BK, Dutta A, Sarkar A, Podder G, Dutta D, Biswas A. “Protocol for the development of a comprehensive telestroke network to improve stroke care in developing countries: The TeStNet trial.” Int J Non Commun Dis: 2025; 10:41-7. 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

India is a country where majority of the population live in the rural areas where evidence based stroke care is lacking as most of the neurologists, stroke specialists, and stroke-ready hospitals are located in major cities far from the reach of the rural population. Stroke awareness is lacking amongst many people resulting in unnecessary delay in seeking proper medical attention and timely presentation to a stroke-ready hospital. Telemedicine can be utilised to provide expert guidance to remote hospitals which are within the reach of the rural population. Availability of stroke experts via telemedicine can convert these hospitals to stroke-ready hospitals and improve the overall stroke care. Telemedicine can also be utilised to connect the community level health workerswith the stroke experts to raise stroke-related awareness and reduce prehospital delay. In this study our aim is to explore the efficacy of telemedicine in reducing stroke-related morbidity and mortality in hospitals connected to a neurology facility in comparison with similar hospitals lacking telemedicine facility. We also want to study the efficacy of telemedicine in the reduction of prehospital delayby connecting community level health workers with stroke experts. In this quasi-experimental study we will evaluate and compare the efficacy of two intervention models, namely ‘Comprehensive Telestroke model’ which not only provides telemedicine support to a remote hospital but also raises community awareness to reduce prehospital delay, and ‘Conventional Telestroke model’ which provides telemedicine support only but does not address the community awareness component.

 
Close